Novartis sells phase 3 rare disease drug to Pharming | Fierce Biotech
A World of Opportunity
Six Novartis Korea Managers Indicted Over Illegal Payments to Doctors - WSJ
It Paid Doctors Kickbacks. Now, Novartis Will Pay a $678 Million Settlement. - The New York Times
Novartis hi-res stock photography and images - Page 13 - Alamy
Teva Pharma appoints Novartis, Biogen vet as new president and CEO – PharmaLive
AGC Biologics to buy Novartis facility in Longmont – Colorado Hometown Weekly
NOVN Stock Price and Chart — SIX:NOVN — TradingView
Novartis Q1 earnings drop as cancer drug sales falter | Pharmafile
Novartis offre à Sandoz son autonomie et une cotation sur SIX | Radio Lac
NOVN: Novartis AG Stock Price Quote - SIX Swiss Ex - Bloomberg
Six Former and Current Novartis AG Execs Charged With Bribing Doctors in Korea | BioSpace
Novartis' Zykadia nears first-line lung cancer label - PMLiVE
Novartis - YouTube
Primary analysis results from Novartis pivotal JULIET trial show Kymriah(TM) (tisagenlecleucel) sustained complete responses at six months in adults with r/r DLBCL, a difficult-to-treat cancer
BioCentury - Marti leaving Novartis Oncology legal team
HazardEx - Novartis plant leak causes hospitalisation of six workers
Alcon becomes a separately traded standalone company | Novartis
Novartis pays $100M for Mallinckrodt's priority review voucher
Novartis's nuclear vision starts to take shape | Evaluate
